Dear KJ: Unfortunately, what you’re experiencing is the common failure to understand that patients and their care partners don’t automatically come from a medical background. No matter how busy an ...

Cassava will stop developing simufilam for Alzheimer’s this year after a Phase 3 trial failed to improve cognition and daily ...

How does design fail or succeed in creating an inclusive experience for all? As CEO of Michael Graves Design, I am deeply ...

Patient-reported outcomes measures in generalized myasthenia gravis (gMG) are more important than ever, for both those ...

Hamas attacks in Israel and subsequent war in Gaza, Ross Glick’s inbox flooded with tips, photos, video and information about ...

Long-term care can cost upwards of $100,000 per year and many expenses are not covered by Medicare or private insurance. Here ...

These are data to week 26 on the monoclonal antibody and antineoplastic agent; data out to week 52 of the MINT trial will be ...